Tammenoms Bakker Juliet
SEC insider (Form 3/4/5 filer). CIK 0001431159. Director at RxSight, Inc. (RXST) and 1 other issuer. 7 reported Form 4/5 transactions since Sep 2024; latest on Jun 17, 2026. Located in SUNNYVALE, CA.
Companies Tammenoms Bakker Juliet has filed insider reports for
- RxSight, Inc. (RXST): Director
- Ceribell, Inc. (CBLL): Director
Tammenoms Bakker Juliet
CIK: 0001431159
Transaction Breakdown
Open Market Buys (P)1 (14.3%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)5 (71.4%)
Compensation grants
Other (G, F, J, C, D, …)1 (14.3%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Jun 17, 2026RXST
RxSight, Inc.
AwardDirect37K shares- - Jun 2, 2026CBLL
Ceribell, Inc.
AwardDirect7.8K shares- - Jun 10, 2025CBLL
Ceribell, Inc.
AwardDirect8.8K shares- - Jun 3, 2025RXST
RxSight, Inc.
AwardDirect10.8K shares- - Oct 15, 2024CBLL
Ceribell, Inc.
ConversionIndirect2.1M shares- - Oct 15, 2024CBLL
Ceribell, Inc.
PurchaseIndirect237.2K shares at avg. $17.00$4.0M - Oct 11, 2024CBLL
Ceribell, Inc.
AwardDirect6.6K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 17, 2026 |  RXST RxSight, Inc. | Award | 37,037 | - | $0 | Direct |
| Jun 2, 2026 |  CBLL Ceribell, Inc. | Award | 7,838 | - | $0 | Direct |
| Jun 10, 2025 | CBLL Ceribell, Inc. | Award | 8,828 | - | - | Direct |
| Jun 3, 2025 | RXST RxSight, Inc. | Award | 10,752 | - | - | Direct |
| Oct 15, 2024 | CBLL Ceribell, Inc. | Conversion | 2,140,600 | - | $0 | Indirect |
| Oct 15, 2024 | CBLL Ceribell, Inc. | Purchase | 237,234 | $17.00 | $4,032,978 | Indirect |
| Oct 11, 2024 | CBLL Ceribell, Inc. | Award | 6,618 | - | $0 | Direct |
1-7 of 7 transactions